
Sign up to save your podcasts
Or


If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
By The Observer4.6
1515 ratings
If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.

851 Listeners

632 Listeners

981 Listeners

170 Listeners

256 Listeners

3 Listeners

25 Listeners

3,401 Listeners

71 Listeners

3,033 Listeners

993 Listeners

1,171 Listeners

756 Listeners

54 Listeners

47 Listeners

36 Listeners

485 Listeners

857 Listeners

336 Listeners

1 Listeners

14 Listeners

21 Listeners

51 Listeners

4 Listeners

170 Listeners

5 Listeners

11 Listeners

13 Listeners

81 Listeners

5 Listeners